CD8A and Alzheimer disease: In addition to CD8+ T cells, the upregulation of PD-L1 expression on the cell surface was observed in CD3+CD56+ (NCAM) T cells, CD4+ T cells, and CD4+CD25+ (IL-2RA) T cells in the AD patients (Fig. 2B).